Ishare Nq Biotch ETF (IBB) 262.10 $IBB iShares Nasdaq

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ishare Nq Biotch ETF (IBB) 262.10 $IBB

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 1.80%
Comtex SmarTrend(R) - Tue Jun 21, 12:19PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $252.86 to a high of $259.50. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $256.34 on volume of 785,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 262.10 (+5.54)

Vista Partners Publishes June 2016 Macroeconomic & Investment Newsletter
Marketwire Canada - Tue Jun 21, 8:01AM CDT
Topics Include: Monthly Macroeconomic Commentary, Investment Considerations, Big Data, Biotechnology, Fintech, Healthcare, IoT, SaaS, Sports, WearableTech & More
IBB: 262.10 (+5.54), IMNP: 0.44 (-0.01)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 1.20% Sell Off
Comtex SmarTrend(R) - Fri Jun 17, 12:13PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $257.55 to a high of $262.99. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $258.19 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 262.10 (+5.54)

After Yesterday's Decline of 1.11%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jun 13, 12:09PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $264.04 to a high of $269.98. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $266.20 on volume of 893,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 262.10 (+5.54)

The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology, Biogen, Alexion Pharma, BioMarin Pharma and Regeneron
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 8:30AM CDT
The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology, Biogen, Alexion Pharma, BioMarin Pharma and Regeneron
BIIB: 238.62 (+4.02), BMRN: 83.65 (+1.47), ALXN: 123.57 (+2.16), IBB: 262.10 (+5.54), REGN: 357.14 (+5.22)

4 Stocks That Crushed the Biotechnology ETF (IBB) This Week
Eric Dutram - Zacks Investment Research - Fri Jun 10, 12:15PM CDT
It was a rough week for the biotechnology ETF (IBB). Which stocks pushed this key sector fund lower for the week?
BIIB: 238.62 (+4.02), BMRN: 83.65 (+1.47), SRPT: 17.88 (+0.47), ALXN: 123.57 (+2.16), IBB: 262.10 (+5.54), REGN: 357.14 (+5.22)

Watch for iShares Nasdaq Biotechnology Index to Potentially Rebound After Falling 2.31% Yesterday
Comtex SmarTrend(R) - Tue Jun 07, 11:58AM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $277.30 to a high of $282.65. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $277.93 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 262.10 (+5.54)

A Catalyst for Biotech ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Mon Jun 06, 7:00AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, is up 9.2% over the past month. Performances for some rival biotech ETFs have been even better and that may be setting the stage for once beloved...
FBT: 91.44 (+2.04), XBI: 54.52 (+1.22), IBB: 262.10 (+5.54)

Trying to Believe in Biotech ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Jun 03, 7:00AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs are vexing investors this year. Just when turnarounds for these funds look legitimate, they tumble again, prompting investors...
FBT: 91.44 (+2.04), XBI: 54.52 (+1.22), IBB: 262.10 (+5.54)

A Fed Focused on Legacy?
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Jun 03, 7:00AM CDT
Note: This article appears on the ETFtrends.com Strategist Channel By Dr. Vito Sciaraffia Federal Reserve Chairperson Paul Volker is remembered for taming the rampant inflation of the late 1970s-early 1980s. Present Chairperson Janet Yellen and her...
FBT: 91.44 (+2.04), XBI: 54.52 (+1.22), IBB: 262.10 (+5.54)

Finally A Biotech ETF Bounce?
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Jun 01, 7:30AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs have been tempting, even teasing investors with signs the group may be ready to rebound this year only to let market...
BIS: 40.63 (-1.82), FBT: 91.44 (+2.04), XBI: 54.52 (+1.22), IBB: 262.10 (+5.54), LABD: 37.40 (-2.88)

iShares Nasdaq Biotechnology Index Rises 1.43% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue May 31, 12:27PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $277.50 to a high of $281.15. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $276.19 on volume of 927,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 262.10 (+5.54)

After Yesterday's Rally of 1.43% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue May 31, 12:25PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $277.50 to a high of $281.15. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $276.19 on volume of 927,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 262.10 (+5.54)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.44% Rise
Comtex SmarTrend(R) - Tue May 24, 2:12PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $266.91 to a high of $270.96. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $268.25 on volume of 584,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 262.10 (+5.54)

Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 1.44% Yesterday
Comtex SmarTrend(R) - Tue May 24, 2:10PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $266.91 to a high of $270.96. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $268.25 on volume of 584,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 262.10 (+5.54)

15 Most Read ETF Articles of the Week (May 16-20)
editor@etftrends.com (ETF Trends) - ETF Trends - Fri May 20, 4:34PM CDT
Each day ETFtrends.com publishes news, strategy and commentary on ETFs in the realms of Commodities, Currency, Equities and Smart-Beta to name a few. Here’s a look at the Top 15 Most Viewed Articles of the Week on ETF Trends, May 16-20, 2016. Click...
USO: 11.98 (+0.24), SCHZ: 53.13 (-0.06), MLN: 20.82 (-0.08), HYMB: 59.33 (-0.03), HYD: 32.04 (-0.04), FBT: 91.44 (+2.04), GREK: 8.29 (+0.37), XBI: 54.52 (+1.22), IBB: 262.10 (+5.54), BNO: 15.39 (-0.47), BNDX: 54.82 (-0.14), PPLT: 92.78 (-1.26), PGX: 15.16 (+0.01), SGOL: 122.49 (-0.89), FVD: 26.76 (+0.31), BSV: 80.62 (-0.09), RVNU: 27.70 (+0.02), MORT: 21.08 (+0.11), REM: 10.02 (+0.04), GLD: 120.11 (-0.79), PFF: 39.74 (+0.06), AGG: 111.28 (-0.19), IAU: 12.12 (-0.08), BND: 83.23 (-0.15)

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 1.13% Gain
Comtex SmarTrend(R) - Wed May 18, 12:26PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $257.80 to a high of $263.77. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $262.86 on volume of 802,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 262.10 (+5.54)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Comprehensive Update on Voting Rights and Share Capital Status

Updated Category News Views 63

URW SE stirred the pot back in September when they updated their voting rights and share capital. With a hefty total of 139,370,486 shares, this company is a real heavyweight in the European market. Shareholders can flex some serious muscle when it comes to company decisions. It's not just about holding shares; it's about wielding influence where it counts. Voting Rights:...

Continue Reading
Veteran Realtor Kate Johnson Earns Inner Circle Honor

Updated Category News Views 10

Decades of Real Estate Mastery under Kate Johnson's Belt In a world where the real estate market twists and turns like a seasoned poker player, Kate Johnson stands tall as a beacon of consistency and trust. Over five decades—yes, you heard it right, more than 51 years—she's been slicing through the complexity of the residential real estate landscape like a hot knife...

Continue Reading
JPMorgan Supports Homeowners Affected by Wildfires

Updated Category News Views 164

JPMorgan Chase Assists Homeowners During Wildfire Crisis In response to the recent wildfires impacting many communities, JPMorgan Chase (NYSE: JPM) has stepped up to offer significant support to its mortgage customers. The bank's home lending unit has introduced a disaster forbearance program specifically designed to assist homeowners affected by these devastating events....

Continue Reading
Investigation Launched on Brookline Bancorp Sale to Berkshire

Updated Category News Views 205

Halper Sadeh LLC Investigates Brookline Bancorp's Sale In a significant move that has caught the attention of investors and financial experts alike, Halper Sadeh LLC has announced its investigation regarding the sale of Brookline Bancorp, Inc. (NASDAQ: BRKL) to Berkshire Hills Bancorp, Inc. This is regarding whether the terms of the sale—0.42 shares of Berkshire common...

Continue Reading
Investigating SARS-CoV-2: Understanding Orphan Genes Role

Updated Category News Views 217

Orphan Genes and COVID-19 Severity The recent discoveries related to orphan genes in the SARS-CoV-2 virus signify a promising avenue for advancing our understanding of COVID-19. Researchers from an international collaborative team have identified an orphan gene within the virus that plays a crucial role in determining the severity of COVID-19. This research could not only...

Continue Reading